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Mitochondrial Ca2+ uptake is an important mediator
of metabolism and cell death. Identification of com-
ponents of the highly conserved mitochondrial Ca2+
uniporter has opened it up to genetic analysis in
model organisms. Here, we report a comprehensive
genetic characterization of all known uniporter com-
ponents conserved inDrosophila. While loss of pore-
forming MCU or EMRE abolishes fast mitochondrial
Ca2+ uptake, this results in only mild phenotypes
when young, despite shortened lifespans. In
contrast, loss of the MICU1 gatekeeper is develop-
mentally lethal, consistent with unregulated Ca2+ up-
take. Mutants for the neuronally restricted regulator
MICU3 are viable with mild neurological impairment.
Genetic interaction analyses reveal that MICU1 and
MICU3 are not functionally interchangeable. More
surprisingly, loss of MCU or EMRE does not sup-
pressMICU1mutant lethality, suggesting that this re-
sults from uniporter-independent functions. Our data
reveal the interplay among components of the mito-
chondrial Ca2+ uniporter and shed light on their phys-
iological requirements in vivo.
INTRODUCTION
The uptake of Ca2+ into mitochondria has long been estab-
lished as a key regulator of an array of cellular homeostatic pro-
cesses as diverse as bioenergetics and cell death (Granatiero
et al., 2017; Mammucari et al., 2016). A series of seminal dis-
coveries has elucidated the identity of the components that
make up the mitochondrial Ca2+ uniporter complex. The
mammalian uniporter is composed of MCU (mitochondrial cal-
cium uniporter) as the main pore-forming protein (De Stefani
et al., 2011; Baughman et al., 2011); its paralog MCUb (Raf-
faello et al., 2013); a small structural component, EMRE (essen-
tial MCU regulator) (Sancak et al., 2013); and the regulatory
subunits MICU1–MICU3 (mitochondrial calcium uptake 1–3)Cell
This is an open access article und(Perocchi et al., 2010; Plovanich et al., 2013; Patron et al.,
2019). Reconstitution studies in yeast, which lacks a mitochon-
drial Ca2+ uniporter, have demonstrated that heterologous co-
expression of MCU and EMRE is necessary and sufficient to
confer uniporter activity (Kova´cs-Bogda´n et al., 2014). The fam-
ily of EF-hand-containing proteins (MICU1, MICU2, and MICU3)
has been shown to exhibit a gatekeeper function for the uni-
porter, inhibiting Ca2+ uptake at low cytoplasmic concentra-
tions (Mallilankaraman et al., 2012; Kamer et al., 2017; Patron
et al., 2019). These components are generally highly conserved
across eukaryotes, including most metazoans and plants, but
not in many fungi and protozoans, reflecting their ancient and
fundamental role (Bick et al., 2012).
Although the composition and function of the uniporter have
been well characterized in vitro and in cell culture models, the
physiological role of the uniporter is beginning to emerge with
in vivo characterization of knockout mutants (Liu et al., 2017).
Current data present a complex picture. Initial studies of
MCU knockout mice described a viable strain with a modest
phenotype in a mixed genetic background (Pan et al., 2013),
although subsequent studies using an inbred background re-
ported MCU loss to be lethal or semi-viable (Murphy et al.,
2014) and tissue-specific conditional knockout revealed an
important role in cardiac homeostasis (Luongo et al., 2015).
Similarly, loss of MICU1 in mice has a complex phenotype,
varying from fully penetrant perinatal lethality (Antony et al.,
2016) to incomplete lethality with a range of neuromuscular de-
fects that unexpectedly improve over time in surviving animals
(Liu et al., 2016).
One explanation for the reported phenotypic variability is that
perturbing mitochondrial Ca2+ uptake can be influenced by
additional factors, the most obvious being genetic background.
Hence, there is a need for greater investigation into the physi-
ological consequences of genetic manipulation of the uniporter
components in a genetically powerful model system. Here we
report a comprehensive genetic analysis of the uniporter com-
plex components that are conserved in Drosophila. This in-
cludes loss-of-function mutants for MCU, EMRE, MICU1, and
MICU3 (Drosophila lack MCUb and MICU2) and corresponding
inducible transgenic expression lines. Despite lacking fast Ca2+
uptake, MCU and EMRE mutants present a surprising lack ofReports 27, 1541–1550, April 30, 2019 ª 2019 The Author(s). 1541
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. The MCU1 Mutant Abolishes Fast
Mitochondrial Ca2+ Uptake and Shortens
Lifespan without Affecting Organismal Phe-
notypes despite Respiratory Defects
(A) Overview of the MCU (CG18769) 50 gene
region (from FlyBase), including the neighboring sfl
(sulfateless). The P{EPgy2}EY08610 transposable
element used to generateMCU1 is displayed, along
with the location of the MCU1 breakpoints.
(B) Western blot analysis of MCU1. Immunoblots
were probed with the indicated antibodies. The
asterisk denotes a non-specific band. Mitochon-
drial ATP5A is used as a loading control.
(C) Representative traces of Ca2+ uptake in mito-
chondria isolated from adult flies of the indicated
genotypes after addition of 45 mM CaCl2. Extra-
mitochondrial Ca2+ was measured by calcium
green-5N fluorescence. Ca2+ was released from
mitochondria by addition of 1 mMFCCP. Addition of
theMCU inhibitor ruthenium red (RuR; 2 mM) blocks
mitochondrial Ca2+ uptake, which is mirrored by
MCU1. Mitochondrial Ca2+ uptake is restored
by transgenic re-expression of MCU driven by
da-GAL4.
(D) Relative uptake kinetics of traces shown in (C)
were determined through linear fits of the initial
phase of Ca2+ uptake and normalized to the wild-
type control (mean ± SEM, n = 3).
(E) Lifespan curves of MCU1 male flies compared
with control and transgenic rescue (MCU1 + MCU)
driven by da-GAL4. Statistical analysis: Mantel-Cox
log-rank test (nR 80).
(F) Climbing assay of control (a precise excision
revertant, MCUrv) and MCU1 flies 2 and 20 days
post-eclosion. Significance measured by Kruskal-
Wallis test with Dunn’s post hoc correction for
multiple comparisons (mean ± 95% confidence
interval (CI); n > 70; *p < 0.05; ns, non-significant).
(G) Relative ATP levels from control andMCU1 flies.
Statistical analysis: unpaired t test (mean ± SD;
n = 2–3; ****p < 0.0001; ns, non-significant).
(H) Oxygen consumption rate (OCR) of control and
MCU1 flies at 3 and 20 days post-eclosion. Statis-
tical analysis: unpaired t test (mean ± SEM; n = 3;
**p < 0.01, ***p < 0.001).
The control genotype is w1118 unless otherwise
stated. See also Figures S1 and S2.organismal phenotypes, although both mutants are short lived,
with a more pronounced effect when MCU is lost. In contrast,
loss of MICU1 causes developmental lethality, whereas mu-
tants for MICU3 are viable with modest phenotypes. Perform-
ing genetic interaction studies with these strains, we confirm
the gatekeeper function of MICU1 is conserved in flies and
reveal that MICU1 and MICU3 are not functionally interchange-
able. More surprisingly, we find that loss ofMCU or EMRE does
not suppress MICU1 mutant lethality, suggesting that the
lethality results from MCU-independent functions. The genera-
tion of these genetic tools in Drosophila will facilitate further
investigation of the functional roles of the uniporter compo-
nents in vivo.1542 Cell Reports 27, 1541–1550, April 30, 2019RESULTS
To generate null mutants for MCU, we used a P element
mobilization technique exploiting a transposon at the 50 end,
P{EPgy2}MCUEY08610 (Figure 1A). We isolated a single imprecise
excision: a deletion of 1,557 bp removing the 50 end ofMCU that
includes the first three exons containing the start codon and
mitochondrial targeting sequence common to most isoforms.
We refer to this mutation as MCU1 (Figure 1A). Precise excision
revertants were also recovered (see STAR Methods). TheMCU1
deletion can be detected by genomic PCR, and the breakpoints
were verified by Sanger sequencing (Figure S1A). The neigh-
boring genes, sulfateless (sfl) and javelin (jv), remained intact
and showed unaltered levels of expression (Figures S1B and
S1C). Immunoblot analysis of crude mitochondrial extracts
from homozygous MCU1 mutant homogenates using an anti-
body raised against the C terminus of Drosophila MCU
confirmed the absence of MCU protein (Figure 1B).
Mitochondria from human or mouse cells lacking MCU fail to
perform fast Ca2+ uptake (Baughman et al., 2011; De Stefani
et al., 2011; Pan et al., 2013). To verify that MCU1 represents a
functional null mutant, mitochondria were isolated from homozy-
gous MCU1 adult flies and assayed for Ca2+ uptake. Similar to
mammalian cells, the addition of Ca2+ to purified, energized
mitochondria from wild-type Drosophila yields a rapid spike of
extra-mitochondrial calcium green-5N fluorescence followed
by a progressive decline in fluorescence as Ca2+ is buffered by
mitochondria (Figures 1C and 1D). Ca2+ is released again upon
depolarization by the uncoupling agent carbonyl cyanide-4-(tri-
fluoromethoxy)phenylhydrazone (FCCP), as reflected by the
concomitant rise in calcium green-5N fluorescence. As ex-
pected, rapid Ca2+ uptake is blocked by the addition of the
MCU inhibitor ruthenium red (RuR). This effect is fully replicated
inMCU1 mutant mitochondria, reflecting a complete loss of fast
Ca2+ uptake. The lack of Ca2+ uptake was not due to loss of
membrane potential, because this was equivalent across the
samples (Figures S1D and S1E). Moreover, Ca2+ uptake is
restored upon transgenic expression of MCU (Figures 1C and
1D; Figures S1D and S1E). Altogether, these data show that
MCU1 is a null mutant incapable of fast Ca2+ uptake.
Despite this deficiency, MCU1 mutants are homozygously
viable and develop to adult stage in expectedMendelian propor-
tions (Figure S1F). However, MCU1 mutants are significantly
shorter lived than controls (34% reduction of median lifespan),
a phenotype that is fully rescued by ubiquitous expression of
transgenic MCU (Figure 1E). Despite this attenuated longevity,
MCU1 mutants do not display an appreciable decline in vitality,
as assessed by analyzing their motor ability using a negative
geotaxis (climbing) assay (Figure 1F).
We next sought to determine the effect of MCU loss on mito-
chondrial metabolic function. Young MCU1 mutants showed a
modest but significant decrease in basal ATP levels compared
to controls (Figure 1G), which ameliorated with age. In contrast,
measurement of oxygen consumption rate (OCR) revealed a
marked reduction in complex I- or complex II-linked respiration
in young andolder flies (Figure 1H). Assessing the impact onmito-
chondrial cell biology, we found no difference in mitochondrial
morphology in flight muscle (Figure S2A) or mitochondrial axonal
transport (Figures S2B and S2C). Altogether, these results indi-
cate that loss of MCU affects mitochondrial respiratory capacity,
but this is surprisingly well tolerated at the organismal level.
To mutate EMRE, we used a CRISPR/Cas9-based approach
(Port et al., 2014) with two simultaneously expressed transgenic
guide RNAs (gRNAs). We isolated several insertion/deletion
(indel) events resulting in frameshift mutations that led to prema-
ture stop codons. Three such mutations are shown in Figure 2A.
As with MCU1, analysis of these EMRE mutants revealed that
they all exhibit no fast mitochondrial Ca2+ uptake (Figures 2C
and 2D), in normally energized mitochondria (Figures S3B and
S3C), indicating that the three mutants are functionally equiva-
lent. We focused on one mutant, EMRE1, whose mutation abol-ishes a BcnI restriction site (Figure S3A) and shows a substantial
reduction in the level of the mRNA transcript (Figure 2B), for
further characterization.
Similar to theMCU1 flies, EMRE1 mutants are viable, eclose at
expected Mendelian ratios (Figure S3D), and display a signifi-
cantly shortened lifespan (23% reduction of median lifespan
compared to control) (Figure 2E). The climbing ability of EMRE1
mutants was similar to that of heterozygous controls at 2 days
old, although a modest difference becomes apparent by
20 days (Figure S3E). This is mirrored in the basal ATP level of
EMRE1 mutants, being only marginally reduced at 20 days (Fig-
ure 2F). However, in contrast to the strong reduction in respira-
tion seen in MCU1 mutants, the complex I- or complex II-linked
respiration of EMRE1 flies is either non-significant or only
modestly affected compared to controls (Figure 2G).
To targetMICU1, we again used P element mobilization, using
P{SUPor-P}MICU1KG04119, and isolated a large deletion span-
ning 11 kb, removing half of MICU1 and extending some 9 kb
upstream of MICU1 (Figure 3A). This region is relatively gene
sparse and devoid of additional predicted protein-coding genes.
Expression analysis of homozygous MICU132 larvae yielded no
detectable transcript, establishing it as a null allele (Figure 3B).
In contrast to MCU and EMRE mutants, homozygous MICU132
mutants are larval lethal, with a few animals reaching the third
instar stage. Supporting this, ubiquitous expression of two inde-
pendent RNAi transgenes also caused developmental lethality.
Because MICU132 mutants do not reach adulthood, we
analyzed larval locomotion (crawling) as a measure of organ-
ismal vitality, revealing a behavioral deficit (Figure 3C).We further
found that these mutants had significantly lower ATP levels
compared to controls (Figure 3D), indicative of a substantial
mitochondrial impairment. This prompted us to investigate other
indicators of mitochondrial homeostasis. Visualizing mitochon-
dria in larval epidermal cells, themorphology looked comparable
to controls, although the mitochondria were more diffuse in the
MICU132 mutants occupying a smaller area of the cell (Figures
3E and 3F). Furthermore, mitochondrial axonal transport was
significantly reduced in MICU132 larvae (Figures 3G and 3H).
Collectively, these data reveal the presence of multiple mito-
chondrial defects that together might be responsible for lethality
of the MICU132 mutants.
MICU132 lethality was fully rescued upon ubiquitous expres-
sion of hemagglutinin (HA)-tagged MICU1 by either the A or
the B isoform (Figure 3I). In addition, organismal vitality, as
measured by climbing ability, was restored (Figure 3J), demon-
strating that these phenotypes are specifically due to loss of
MICU1.
Drosophila do not have an ortholog of the MICU1 paralog
MICU2, but MICU3 is conserved, encoded by CG4662 (Fig-
ure 4A). Similar to mammals (Patron et al., 2019), Drosophila
MICU3 also appears to be mainly expressed in neuronal tissue
(see FlyBase and Graveley et al., 2011). Little is known about
the function of MICU3, and no in vivo studies have been re-
ported. To assess its role in vivo, we used CRISPR/Cas9 to
induce indel mutations. One of these mutations,MICU327, a sin-
gle-base deletion (Figure 4B; Figure S4A) that abolishes a MboII
restriction site (Figure S4B), leads to a frameshift and early trun-
cation. This mutation also substantially de-stabilizes the MICU3Cell Reports 27, 1541–1550, April 30, 2019 1543
Figure 2. EMRE Mutants Exhibit No Fast
Mitochondrial Ca2+ Uptake and Are Short
Lived but Have Mild Phenotypes
(A) Sequence alignments of wild-type and EMRE
mutants, with predicted protein sequences and
positions of gRNA recognition sites (colored text).
the box denotes the BcnI cleavage site.
(B) Relative expression of EMRE transcript for
control and EMRE1 mutants (mean ± SD; n = 3).
(C) Representative traces of Ca2+ uptake in mito-
chondria isolated from adult flies of the indicated
genotypes after addition of 45 mM CaCl2. Extra-
mitochondrial Ca2+ was measured by calcium
green-5N fluorescence. Ca2+ was released from
mitochondria by addition of 1 mM FCCP. EMRE
mutations prevent mitochondrial Ca2+ uptake
equivalent to the inhibitor ruthenium red (RuR;
2 mM).
(D) Relative uptake kinetics were determined
through linear fits of Ca2+ uptake traces and
normalized to controls (mean ± SEM; n = 3).
(E) Lifespan curves of EMRE1 male flies compared
with control. Statistical analysis: Mantel-Cox log-
rank test (nR 91).
(F) Relative ATP levels from control and EMRE1
flies. Statistical analysis: unpaired t test (mean ±
SD; n = 3; ns, non-significant).
(G) Oxygen consumption rate (OCR) of control
and EMRE1 flies at 3 and 20 days post-eclosion.
Statistical analysis: unpaired t test (mean ± SEM;
n = 3; *p < 0.05).
The control genotype isw1118 in all cases. See also
Figure S3.transcript (Figure 4C). In contrast to loss ofMICU1, homozygous
MICU327 mutants are fully viable (Figure S4C), though lifespan
was modestly (7% reduction in median lifespan) but significantly
reduced (Figure 4D). In addition, these mutants exhibited a sig-
nificant climbing defect in young and older flies (Figure S4D).
These results indicate a function for MICU3 in proper mainte-
nance of neuronal function, consistent with its neuronally
restricted expression. However, analyzing mitochondrial respi-
ration from heads of MICU327 mutants, we observed no signifi-
cant differences in young and older flies compared to control
(Figure 4E).1544 Cell Reports 27, 1541–1550, April 30, 2019To investigate the functional relation-
ships among the various uniporter
components, we undertook several ge-
netic interaction studies. First, because
Drosophila MICU1 and MICU3 share a
fair degree of homology (49% similarity
and 31% identity between MICU1-B
and MICU3-C), we reasoned that they
may share some functional overlap. To
address this, we asked whether normally
neuronally restricted MICU3 could func-
tionally substitute for MICU1. Thus, we
ectopically expressed MICU3 ubiqui-
tously in MICU132 mutants. Here we
chose to express isoforms A and C,because these cover all predicted coding regions (Figure 4A).
However, neither MICU3 isoform was able to restore viability of
MICU132 mutants or shift the lethal phase (Figure 3I), indicating
that MICU3 is not functionally equivalent to MICU1 in vivo.
MICU1 has been shown to provide a gatekeeper function for
the uniporter channel, with loss of MICU1 causing unregulated
mitochondrial Ca2+ uptake. It has also been shown that in mice
lackingMICU1, genetic reduction of EMRE substantially amelio-
rates the MICU1 phenotypes (Liu et al., 2016). Thus, we
reasoned that the lethality of the MICU132 mutants is caused
by unregulated Ca2+ entry, which should be prevented by loss
Figure 3. MICU132Mutants Are Lethal, Have
Reduced ATP and Mitochondrial Transport,
and Are Not Rescued by MCU1 or EMRE1
(A) Overview of the MICU1 (CG4495) gene region
(from FlyBase). The P{SUPor-P}MICU1KG04119
transposable element used to generate MICU132
is displayed, as well as the deleted region in
MICU132.
(B) Relative expression of MICU1 transcript for
control and MICU132 larvae (mean ± SD; n = 3).
(C) Larval crawling of control andMICU132 larvae,
expressed as the number of peristaltic waves per
minute. Statistical analysis: unpaired t test
(mean ± 95% CI; n = 10; **p = 0.0034).
(D) Relative ATP levels from control and MICU132
larvae. Statistical analysis: unpaired t test (mean ±
SD; n = 4; **p = 0.0011).
(E) Quantification of mitochondrial density in the
images shown in (F) (zoomed images). Statistical
analysis: one-way ANOVA (mean ± SD; n = 4;
*p < 0.05; ns, non-significant).
(F) Confocal microscopy analysis of epidermal
cells in control and MICU132 larvae immuno-
stained with the mitochondrial marker anti-ATP5A.
Boxed areas are enlarged to the right. Scale bars:
10 mm (left), 4 mm (right).
(G) Representative kymographs of mitochondrial
axonal transport in control and MICU132 larvae.
Scale bars: 10 mm (horizontal), 50 s (vertical). Ge-
notypes—control: M12-GAL4, UAS-mito-HA-
GFP/+. MICU132: MICU132/MICU132; M12-GAL4,
UAS-mito-HA-GFP/+.
(H) Quantification of mitochondrial transport
shown in (G). Statistical analysis: one-way ANOVA
(mean ± 95% CI; n = 6 (control) and 11 (mutant);
**p < 0.01, ****p < 0.0001; ns, non-significant).
(I) Table of viability of MICU132 rescue by trans-
genic expression of MICU1 or MICU3 isoforms or
loss ofMCU or EMRE. Transgenic expression was
induced using ubiquitous drivers: arm-GAL4 for
MICU1 and da-GAL4 for MICU3.
(J) Climbing assay of control flies (arm-GAL4/+)
andMICU132 mutants with ubiquitous (arm-GAL4)
driven transgenic re-expression of HA-tagged
MICU1-A and MICU1-B isoforms. Statistical
analysis: Kruskal-Wallis test with Dunn’s post hoc
correction for multiple comparisons (mean ± 95%
CI; nR 40).
The control genotype is w1118 unless otherwise
stated.of the MCU channel. To test this, we combined homozygous
MICU132 and MCU1 mutants and, to our surprise, found that
this did not suppress the lethality or noticeably shift the lethal
phase (Figure 3I). We corroborated this finding by combining
MICU132 mutants with EMRE1 mutants, with the same result
(Figure 3I). Moreover, the aberrant mitochondrial distribution in
MICU132 epidermal cells was not restored by loss of MCU (Fig-
ures 3E and 3F).
Overexpression paradigms disrupting uniporter stoichiom-
etry have previously been used to study the functional relation-
ships of uniporter components (Choi et al., 2017). Using aclassic eye morphology assay as a readout of the impact of ge-
netic interactions on cell and tissue viability, we first found that
overexpression of any of the uniporter components alone in the
eye, using a GMR-GAL4 driver, had no effect on eye or omma-
tidial morphology (Figure S5A), with overexpression confirmed
by immunoblotting (Figures S5B–S5E). This indicates that over-
abundance of any uniporter component, including MCU, is
insufficient to grossly disrupt mitochondrial Ca2+ homeostasis
as expected. However, the co-expression of MCU and EMRE
caused a dramatic disruption of eye morphology with a general
loss of retinal pigment and ommatidia, resulting in a glazedCell Reports 27, 1541–1550, April 30, 2019 1545
Figure 4. MICU3 Loss of Function Is Largely
Benign
(A) Overview of MICU3 (CG4662) gene region
(from FlyBase), including positions of the gRNA
recognition site.
(B) Sequence alignment of wild-type and
MICU327, with relative predicted protein se-
quences. The gRNA recognition site is highlighted
in red. The box denotes the MboII cleavage site.
(C) Relative expression of MICU3 transcript for
control and MICU327 flies (mean ± SD; n = 3).
(D) Lifespan curves of MICU327 male flies
compared with control. Statistical analysis:
Mantel-Cox log-rank test (nR 84).
(E) Oxygen consumption rate (OCR) of control and
MICU327 flies at 3 and 20 days post-eclosion.
Statistical analysis: unpaired t test (mean ± SEM;
n = 4).
The control genotype isw1118 in all cases. See also
Figure S4.appearance with occasional black, necrotic patches (Figure 5A).
This effect is consistent with the cooperative actions of MCU
and EMRE to create the channel, and in line with reconstitution
experiments in yeast showing that expression of mammalian
MCU and EMRE are necessary and sufficient to elicit Ca2+ uni-
porter activity. The gross disruption of eye integrity also dem-
onstrates the catastrophic effects of unregulated mitochondrial
Ca2+ entry.
In contrast, co-expression of MCU with either MICU1 or
MICU3 was not so detrimental, although in all cases, it caused
a mild disruption of the ommatidial arrangement, resulting in a
mild roughened appearance (Figure 5A). This system allowed
us to test possible functional differences among the isoforms
of MICU1 and MICU3. In general, the co-expression of all iso-
forms with MCU caused similar effects, though the expression
of MICU3-C gave a slightly stronger phenotype that may reflect
its greater level of expression compared to MICU3-A (Fig-
ure S5E). The enhanced phenotype of MCU:MICU3 co-expres-1546 Cell Reports 27, 1541–1550, April 30, 2019sion is consistent with a report that
MICU3 enhances MCU-mediated Ca2+
uptake (Patron et al., 2019).
We next reasoned that if the dramatic
eye phenotype caused by MCU and
EMRE co-expression was due to extra
unregulated channels and excessive
Ca2+ uptake, this may be ameliorated by
co-expression of the MICU1 gatekeeper.
Co-expression of either MICU1-A or
MICU1-B with MCU and EMRE pre-
vented the MCU:EMRE phenotype (Fig-
ure 5B). Co-expression of a GFP control
confirmed that this was not due to
titration of multiple upstream activating
sequence (UAS) lines. Although both
isoforms provided excellent rescue, iso-
form B appeared slightly more effective
than isoform A. These observations areconsistent with MICU1 providing the main gatekeeper function
for the uniporter.
We also used this assay to test the functionality of MICU3 in
this context. In contrast to MICU1 expression, co-expression
of either MICU3-A or MICU3-C with MCU and EMRE provided
no suppressing effect for theMCU:EMRE phenotype (Figure 5B).
These results are consistent with MICU3 not being a major uni-
porter gatekeeper in vivo.
DISCUSSION
The capacity of mitochondria to take up Ca2+ has important im-
plications for cellular homeostasis as it regulates fundamental
processes from metabolism to cell death. In this context, the
mitochondrial Ca2+ uniporter plays a crucial function, driving
the rapid entry of Ca2+ into mitochondria. To better understand
the physiological role of mitochondrial Ca2+ uptake, we have
used the genetically powerful model Drosophila to manipulate
Figure 5. Genetic Interactions of Overexpression Uniporter
Components
(A) Flies bearing the eye-specific GMR-GAL4 driver and UAS-MCU transgene
(GMR >MCU) crossed to transgenes of the indicated uniporter components or
to a control (+) w1118 line.
(B) Flies bearing a combination of the eye-specificGMR-GAL4 driver and both
UAS-MCU and UAS-EMRE transgenes (GMR > MCU+EMRE) crossed to
transgenes of the indicated components or to a control (GFP) transgene.
Below the micrograph images are schematic cartoons of the proposed status
of the uniporter based on the composition of the overexpressed components.
Scale bar: 100 mm. See also Figure S5.the conserved set of dedicated channel and regulatory proteins
that form the uniporter complex.
MCU mutants are viable and fertile with no gross morpholog-
ical or behavioral defects, which was initially surprising given the
historical importance of mitochondrial Ca2+. Still, this corrobo-
rates another report of fly MCU mutants (Choi et al., 2017) and
is consistent with studies in mice and worms in which deletion
of MCU orthologs is essentially benign at the organismal level
under basal conditions (Pan et al., 2013; Xu and Chisholm,
2014). However, fly MCU mutants are significantly shorter lived
than controls. This situation is mirrored by EMREmutants, albeit
with a smaller impact on lifespan. The reason for the shortened
lifespans is unknown but may reflect the effects of a chronic bio-
energetic deficit evident from the OCR measurements. Accord-
ingly,MCUmutants show a greater respiration defect compared
to EMRE mutants, consistent with their respective impacts on
lifespan. The respiratory impairment could be due to the previ-
ously reported increase in oxidative stress that occurs in MCU
mutants (Choi et al., 2017), which has yet to be assessed in
EMRE mutants. Alternatively, the short lifespan may be due to
a myriad of potential metabolic imbalances, such as disruption
of NADH/NAD+ levels. Chronic adaptations may also occur
through transcriptional responses. Further studies analyzing
the metabolic and transcriptional changes occurring in these
flies will shed light on this fundamental question.
Nevertheless, the EMRE mutants are relatively benign at the
organismal level, which corroborates the surprising viability of
MCU mutants. Considering this, it is striking that flies, like mice
and worms, consistently show an ability to compensate for the
lack of fast mitochondrial Ca2+ uptake, suggesting the induction
of some adaptive mechanism, as discussed by others (Murphy
et al., 2014; Harrington and Murphy, 2015). While alternative
routes of mitochondrial Ca2+ entry must exist, because matrix
Ca2+ is not abolished in MCU knockout (KO) mice (Pan et al.,
2013), proposed mechanisms are speculative, and it is unclear
whether they constitute a compensatory adaptation for fast
Ca2+ uptake or simply allow gradual, slow accumulation (Har-
rington and Murphy, 2015). However, rapid mitochondrial Ca2+
uptake mediated by MCU is thought to constitute a specific
metabolic regulatory mechanism, e.g., to increase ATP produc-
tion, under certain conditions, such as strenuous exercise or
pathological conditions (Denton, 2009), which is partly evident
in the MCU KO mice (Pan et al., 2013) or heart-specific condi-
tional KO (Luongo et al., 2015). Such important physiological
roles would not necessarily be apparent under basal conditions
in flies. MCU has also been proposed to promote wound healing
(Xu and Chisholm, 2014); however, our preliminary studies did
not find evidence supporting this. The current study presents a
summary of the requirements of uniporter components under
basal conditions, and further work will be needed to evaluate
the role of the uniporter in the full range of physiological
conditions.
In seeking to understand the importance of the regulatory
components of the uniporter, we also developed loss-of-func-
tion models for MICU1 and MICU3. In contrast to MCU and
EMRE mutants, loss of MICU1 results in larval lethality, which
is associated with alterations in mitochondrial distribution and
motility, and a reduced level of total ATP. In line with its role asCell Reports 27, 1541–1550, April 30, 2019 1547
the principle gatekeeper of the uniporter, coupled with excess
mitochondrial Ca2+ triggering cell death, we reasoned that the
lethality was due to Ca2+ accumulation in the mitochondrial ma-
trix through unregulated MCU-EMRE channels. Supporting this,
we observed that dual overexpression ofMCU and EMRE in the
eye leads to substantial loss of retinal tissue; concomitant over-
expression of MICU1 is sufficient to prevent this phenotype,
consistent with MICU1 re-establishing appropriately regulated
uniporter channels.
However, one observation that was most surprising to us was
the inability of MCU or EMRE mutants to rescue the MICU1
mutant lethality. This result is particularly puzzling, because it
has been shown that mice lacking MICU1, which present multi-
ple pathogenic phenotypes, are substantially rescued by genetic
reduction of EMRE levels (Liu et al., 2016). While the reason for
the lack of rescue in flies is unclear, we postulate that this sug-
gests the function of MICU1 is not limited to uniporter-depen-
dent Ca2+ uptake. We do not know whether the lethality of
MICU1 mutants is specifically due to excessive mitochondrial
Ca2+ levels; however, it appears to be independent of fast mito-
chondrial Ca2+ uptake, because this is eliminated in MCU and
EMRE mutants. As noted earlier, other routes of Ca2+ uptake
into mitochondria exist, but the mechanisms that regulate
them are uncertain. It is possible that aberrant manganese up-
take, as reported to occur in cell models, may contribute to the
MICU1 mutant lethality (Kamer et al., 2018; Wettmarshausen
et al., 2018). However, this mechanismwould presumably be ex-
pected to be mitigated by loss of MCU. Nevertheless, these
Drosophila models are ideally suited for unbiased genetic
screening to uncover such fundamental regulatory mechanisms.
In contrast toMICU1, loss ofMICU3was well tolerated overall
at the organismal level. Functional analysis of MICU3 is
extremely limited, but the neuronally restricted expression led
us to anticipate that these mutants might have more neurolog-
ical-specific phenotypes, which was at least partly borne out.
Whereas longevity of thesemutants was only minimally affected,
they exhibited a notable locomotor deficit even in young flies.We
initially hypothesized that MICU3may be able to act redundantly
with MICU1, but attempts to transgenically rescue MICU1 mu-
tants by ectopic MICU3 expression were unsuccessful. This
result is consistent with a report showing that MICU3 binds to
MICU1 but apparently enhances mitochondrial Ca2+ uptake
(Patron et al., 2019).
In summary, we present a comprehensive analysis of the
conserved components of the mitochondrial Ca2+ importer and
its regulators. While loss of the various components results in
dramatically different organismal phenotypes, ranging from the
most severe deficit exemplified by the MICU1 mutants to the
mild consequences of mutating MICU3, such diverse pheno-
types mirror the situation reported in humans so far. The first
described patients with MICU1 mutations exhibit a severe,
complex neurological condition accompanied by muscular dys-
trophy and congenital myopathy, clearly associated with mito-
chondrial dysfunction (Logan et al., 2014), whereas a later study
reportedMICU1 patients with a relatively mild fatigue syndrome
(Lewis-Smith et al., 2016). One explanation for the reported
phenotypic variability is that the consequence of perturbing
mitochondrial Ca2+ uptake can be influenced by additional1548 Cell Reports 27, 1541–1550, April 30, 2019factors, the most obvious being genetic background. The ge-
netic tools described here open up the possibility for a thorough
analysis of the uniporter function in a powerful genetic model
organism, which will advance our understanding of the role of
mitochondrial Ca2+ in health and disease.STAR+METHODS
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Antibodies
Mouse monoclonal anti-ATP5A Abcam RRID:AB_301447; Abcam: ab14748
Rabbit polyclonal anti-HA Abcam RRID:AB_307019; Abcam: ab9110
Mouse monoclonal anti-a-Tubulin, clone DM1A Sigma RRID:AB_477593; Sigma: T9026
Rabbit polyclonal anti-Porin Millipore Millipore PC548; RRID:AB_2257155
Mouse monoclonal anti-V5 Thermo Fisher Scientific Thermo: R960-25; RRID:AB_2556564
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EKAERKY)
Pepceuticals N/A
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NotI FastDigest Thermo Fisher Scientific Thermo: FD0593
XhoI FastDigest Thermo Fisher Scientific Thermo: FD0694
XbaI FastDigest Thermo Fisher Scientific Thermo: FD0684
EcoRI FastDigest Thermo Fisher Scientific Thermo: FD0274
Bovine Serum Albumin Sigma Sigma: A7030
Mannitol Sigma Sigma: M9546
Sucrose Sigma Sigma: S9378
HEPES Sigma Sigma: H3375
EGTA Sigma Sigma: E0396
Taurine Sigma Sigma: T0625
Triton X-100 Sigma Sigma: T8787
Tween 20 Thermo Fisher Scientific Thermo: BP337500
cOmplete, Mini, EDTA-free Protease Inhibitor Cocktail Sigma Roche: 4693159001
2-Mercaptoethanol Sigma Sigma: M6250
MgCl2 Sigma Sigma: M8266
ECL-Prime Sigma Sigma: GERPN2232
4% Formaldehyde Thermo Fisher Scientific Thermo: 28908
Prolong Diamond Antifade Mounting Medium Thermo Fisher Scientific Thermo: P36965
Sylguard Sigma Sigma: 761028
Malate Sigma Sigma: M 1000
Glutamate Sigma Sigma: G 1626
Succinate Sigma Sigma: S 2378
ADP Sigma Sigma: A 5285
Rotenone Sigma Sigma: R 8875
Critical commercial assays
CellTiter-Glo Luminescent Cell Viability Assay Promega Promega: G7570
RNeasy RNA purification kit QIAGEN QIAGEN: 74106
ProtoScript II first strand cDNA Synthesis Kit New England BioLabs NEB: E6560S
DC Protein Assay Kit Bio-Rad N/A
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iQ SYBR Green Supermix Bio-Rad 170-8880
Turbo DNase Free Ambion AM1907
Experimental Models: organisms/strains
D. melanogaster: w[1118] BDSC (RRID:SCR_006457) RRID:BDSC_6326
D. melanogaster: y[1] w[67c23]; P{w[+mC] y[+mDint2] =
EPgy2}MCU[EY01803]
BDSC RRID:BDSC_16357
D. melanogaster: y[1] w[67c23]; P{y[+mDint2]
w[BR.E.BR] = SUPor-P}MICU1[KG04119]
BDSC RRID:BDSC_13588
D. melanogaster: y[1] M{w[+mC] = nos-Cas9.P}ZH-2A w[*] BDSC RRID: BDSC_54591
D. melanogaster: w[*]; Kr[If-1]/CyO; P{w[+mW.hs] =
GAL4-da.G32}UH1
BDSC RRID:BDSC_55850
D. melanogaster: w[*]; P{w[+mW.hs] = GAL4-arm.S}11 BDSC RRID:BDSC_1561
D. melanogaster: w[*]; P{w[+mC] = GAL4-ninaE.GMR}12 BDSC RRID:BDSC_1104
D. melanogaster: y[1] w[*]; P{w[+mC] = CCAP-
GAL4.P}16/CyO
BDSC RRID:BDSC_25685
D. melanogaster: w[*]; P{w[+mW.hs] = GawB}tey
[5053A]/TM6B, Tb[+]
BDSC RRID:BDSC_2702
D. melanogaster: w[1118]; P{w[+mC] = UAS-mito-
HA-GFP.AP}2/CyO
BDSC RRID:BDSC_8442
D. melanogaster: w[1118]; P{w[+mC] = UAS-mito-
HA-GFP.AP}3, e[1]
BDSC RRID:BDSC_8443
D. melanogaster: y[*] w[*];P{w[+mC] = UAS-tdTomato.mito}1 BDSC RRID:DGGR_117015
D. melanogaster: M{UAS-MICU1.ORF.3xHA}ZH-86Fb FlyORF FlyORF Line ID: F000962
Oligonucleotides
MCU1 Forward Primer: GCAACTTCAGCATATGACC This paper N/A
MCU1 Reverse Primer: GGAATTGGGATGCCATAGC This paper N/A
EMRE1 Forward Primer: GCGCTTTTCAACACTACTAC This paper N/A
EMRE1 Reverse Primer: GGTATGACGGCACAGAAGATG This paper N/A
MICU327 Forward Primer: CTCGATCTCTGATCCCGCA This paper N/A
MICU327 Reverse Primer: TCGTGCAGAAAACAACTACATTT This paper N/A
qPCR Primers This paper (See Table S1) N/A
Recombinant DNA
pCFD4 Addgene Addgene: 49411
pUAST-attB Drosophila Genomics Resource
Centre
DGRC: 1419
LD26402 Drosophila Genomics Resource
Centre
DGRC: 2351
IP17639 Drosophila Genomics Resource
Centre
DGRC: 1605128
LD23951 Drosophila Genomics Resource
Centre
DGRC: 7119
RH09265 Drosophila Genomics Resource
Centre
DGRC: 1153329
Software and algorithms
Datlab Oroboros N/A
Prism v7 GraphPad RRID:SCR_002798
Fiji Fiji.sc RRID:SCR_002285
Micro-Manager Micro-manager.org RRID:SCR_016865
Other
Microinjection Services BestGene Inc., or Department of
Genetics, University of Cambridge
N/A
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J. Whitworth (a.whitworth@mrc-mbu.cam.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Flies were raised under standard conditions at 25C on food consisting of agar, cornmeal, molasses, propionic acid and yeast in a
12h:12h light:dark cycle. The following strains were obtained from the Bloomington Drosophila Stock Center (RRID:SCR_006457):
w1118 (RRID:BDSC_6326), MCUEY08610 (RRID:BDSC_16357), MICU1KG04119 (RRID:BDSC_13588), da-GAL4 (RRID:BDSC_55850),
arm-GAL4 (RRID:BDSC_1561),GMR-GAL4 (RRID:BDSC_1104),CCAP-GAL4 (RRID:BDSC_25685),M12-GAL4 (RRID:BDSC_2702),
UAS-mito-HA-GFP (RRID:BDSC_8442, RRID:BDSC_8443), UAS-mito.tdTomato (RRID:DGGR_117015). UAS-MICU1-A-HA
(F000962) was obtained from the FlyORF collection (Bischof et al., 2013). Experimental procedures and fly husbandry were per-
formed in accordance with local Biological Services committee approval.
METHOD DETAILS
Drosophila mutagenesis
Mobilisation of theMCUEY08610 andMICU1KG04119 transposable elementswasused to generateMCU (CG18769) andMICU1 (CG4495)
mutants, termed MCU1 and MICU132. Several precise excisions of the P-elements (revertants) were also recovered. For EMRE
(CG17680) andMICU3 (CG4662), a CRISPR-based strategywas employed. Here, guide RNAs (gRNAs) were evaluated using an online
tool (http://targetfinder.flycrispr.neuro.brown.edu/) (Gratz et al., 2014). Where possible, gRNAs toward the 50 end of the protein coding
sequence without predicted off-targets were selected. gRNAs were cloned into the pCFD4 vector (Addgene 49411), and the resulting
constructswereverifiedbysequencingbeforebeingsent for transgenesisbyphiC31site-directed integration intoattP40andattP2sites
(BestGene Inc., orDepartment ofGenetics,University ofCambridge). These gRNA-expressing flieswere crossed to y1M{nos-cas9,w+}
ZH-2A w* (RRID: BDSC_54591) for mutagenesis. Mutant lines were screened via sequencing of PCR products spanning the targeted
gene region. The mapped breakpoints for each mutant are as follows:MCU1, 3L:6550718-6552274; EMRE1, 2R:18147830-18147821,
2R:18147812-18147804; EMRE2, 2R: 18147814-18147795; EMRE3, 2R:18147805-18147805; MICU132, 2L:7173086-7184065;
MICU327, 3R:19850278-19850278. All genomic coordinates are according to FlyBase/BDGP Release 6 (Gramates et al., 2017). All
the mutants lines used in this study were backcrossed to an isogenicw1118 strain (RRID:BDSC_6326), for 4-6 generations before use.
Generation of transgenic lines
The following transgenes were generated by cloning into the pUAST-attB vector (BestGene Inc.).
UAS-MCU
MCU was amplified from cDNA clone LD26402 (equivalent to isoforms A, B, C and D) and inserted between the NotI and XhoI sites.
UAS-MICU1-B-HA:MICU1-Bwas amplified from cDNA IP17639 to include a single 30 HA tag, andwas inserted between theNotI and
XbaI sites. UAS-EMRE-myc: EMRE was amplified from genomic DNA with primers encoding a single 30 Myc tag, and was inserted
between the EcoRI and XhoI sites.UAS-MICU3-A-V5,UAS-MICU3-C-V5:MICU3-A andMICU3-Cwere amplified from cDNA clones
lD23951 and RH09265 respectively, including a single 30 V5 tag, and were inserted between the NotI and XbaI sites.
All cDNA clones were obtained from Drosophila Genomics Resource Center (Bloomington, Indiana). Constructs were verified by
sequencing before being sent for transgenesis by phiC31 site-directed integration into attP40 and attP2 sites (BestGene Inc., or
Department of Genetics, University of Cambridge). For all integration events, multiple independent lineswere initially isolated, verified
by PCR and assessed for consistent effects before selecting a single line of each integration site for further study.
Mitochondrial membrane potential and calcium flux
Mitochondria were prepared from 50 whole adult flies by differential centrifugation. Samples were homogenized with a Dounce
glass potter and a loose-fitting glass pestle in a mannitol-sucrose buffer (225 mM mannitol, 75 mM sucrose, 5 mM HEPES,
0.1 mM EGTA, pH 7.4) supplemented with 2% BSA. Samples were centrifuged at 1,500 3 g at 4C for 6 min. The supernatant
was filtered through a fine mesh, and centrifuged at 7,000 3 g at 4C for 6 min. The resulting pellet was resuspended in mannitol-
sucrose buffer without BSA before being centrifuged at 7,000 x g under the same conditions as above and resuspended in a small
volume (50 mL) of mannitol-sucrose buffer. Protein concentration was measured using the Biuret test.
Mitochondrial membrane potential of isolated mitochondria was measured based on the fluorescence quenching of
Rhodamine123 (Rh123; Molecular Probes) and mitochondrial Ca2+ fluxes were measured by Calcium Green 5N (Molecular Probes)
fluorescence at 25C (vonStockum et al., 2011) using a Fluoroskan Ascent FL (Thermo Electron) plate reader (excitation and emission
wavelengths of 485 and 538 nm, respectively with a 10 nm bandpass filter) at a mitochondrial concentration of 1 mg/mL. The incu-
bationmedium contained 250mMsucrose, 10mMMOPS-Tris, 5mM/2.5mMglutamate/malate-Tris, 5mMPi-Tris, 10 mMEGTA, and
0.4 mMRhodamine123, or 0.5 mMCalcium Green 5N, pH 7.4. Addition of Ruthenium Red (RuR, 2 mM) was made directly into the well
containing the assay medium before mitochondria were added. Further additions were made as indicated in the figure legends.Cell Reports 27, 1541–1550.e1–e5, April 30, 2019 e3
Locomotor and lifespan assays
Climbing (negative geotaxis assay) was assessed as previously described with minor modifications (Greene et al., 2003). Briefly, for
climbing, 20-25 males were placed into the first chamber of a ‘Benzer’ counter-current apparatus, tapped to the bottom, and given
10 s to climb a 10 cm distance. This procedure was repeated five times, and the number of flies remaining in each chamber was
counted. The weighted performance of several group of flies for each genotype was normalized to the maximum possible score
and expressed as Climbing Index.
For larval locomotion (crawling), mid-third instar larvae were picked from the surface of the food using a brush and cleaned using a
moist Kimwipe. Excessive handling was minimized at all stages. Larvae were assayed individually by placing onto plates containing
freshly set 1% agarose, where they acclimatised for 30 s, after which peristaltic waves were counted for one minute. Larvae of
different genotypes were placed onto different plates, and no more than 6 larvae were assayed for any individual plate.
For lifespan experiments, flies were grown under identical conditions at low-density. Groups of approximately 20-25males of each
genotype were collected under very light anesthesia, placed into separate vials with food and maintained at 25C. Flies were trans-
ferred into vials containing fresh food every 2-3 days, and the number of dead flies was recorded. Percent survival was calculated at
the end of the experiment after correcting for any loss resulting from handling.
Mitochondrial protein enrichment
Crude mitochondrial extracts were obtained from approximately 100 flies per sample. After 5 min on ice, flies were homogenized in a
glass tissue grinder containing 2 mL of cold mitochondrial isotonic buffer (225 mMmannitol, 75 mM sucrose, 5 mM HEPES, 0.5 mM
EGTA, 2 mM taurine, pH 7.25) for 30-60 s until uniform. Subsequently, the homogenates were centrifuged at 5003 g at 4C for 5 min.
The resulting supernatants were passed through a 100 mm nylon sieve (Cell Strainer REF 352360, BD Falcon, USA), centrifuged at
11,0003 g for 10 min at 4C, and pellets were stored at 80C until use. The final mitochondrial pellets were subsequently used for
lysis in 50 mL of RIPA buffer (50 mMTris-HCl, pH 8.0; 150mMNaCl; 1 mMEDTA, 0.5%SDS, 1% (vol/vol) Triton X-100) with cOmplete
mini EDTA-free protease inhibitors (Roche) for 10min on ice. After carrying out three freeze-thaw cycles with dry ice and a 37Cwater
bath, the lysates were centrifuged at 20,000 3 g for 5 min and the supernatants taken for SDS-PAGE.
Immunoblotting
For MCU and EMRE expression analysis, mitochondrial proteins were isolated from whole adult flies according to the method
described in the previous section. For MICU1 and MICU3 overexpression analysis flies were homogenized in a PBS-based lysis
buffer with lithium dodecyl sulfate containing b-Mercaptoethanol and supplemented with cOmplete mini EDTA-free protease inhib-
itors (Roche). Equivalent amounts of proteins were resolved by SDS-PAGE and transferred onto nitrocellulose membrane using a
semi-dry Transblot apparatus (BioRad) according to the manufacturer’s instructions. The membranes were blocked in TBST
(0.15 M NaCl and 10 mM Tris-HCl; pH 7.5, 0.1% Tween 20) containing 5% (w/v) dried non-fat milk (blocking solution) for 1 h at
room temperature and probedwith the indicated primary antibody before being incubatedwith the appropriate HRP-conjugated sec-
ondary antibody. Antibody complexes were visualized by an ECL-Prime enhanced chemiluminescence detection kit (Amersham) us-
ing a ChemiDoc XRS+ molecular imager (BioRad).
Antibodies
For immunoblot experiments, the following antibodies were used: mouse anti-ATP5A (Abcam ab14748; RRID:AB_301447; 1:20000),
rabbit anti-HA (Abcam ab9110; RRID:AB_307019; 1:1000), mouse anti-a-Tubulin (Sigma T9026, clone DM1A; RRID:AB_477593;
1:1500), rabbit anti-Porin (Millipore PC548; RRID:AB_2257155; 1:5000), mouse anti-V5 (Thermo Fisher Scientific R960-25;
RRID:AB_2556564; 1:2000), mouse anti-Myc tag (Cell Signaling, clone 9B11; RRID:AB_331783; 1:800). Horseradish peroxidase-
conjugated secondary antibodies: anti-mouse (Abcam ab6789-1; RRID:AB_955439; 1:5000-1:40000), anti-rabbit (Invitrogen
G21234; RRID:AB_2536530; 1:3000 to 1:5000). Anti-MCU antiserumwas raised in rabbits against a KLH-conjugated C-terminal pep-
tide, RTQENTPPTLTEEKAERKY (Pepceuticals, 1:1000). For immunohistochemistry, tissues were incubated with mouse anti-ATP5A
(Abcam ab14748; RRID:AB_301447; 1:500) and secondary antibody anti-mouse AF488 (Invitrogen: A11001; RRID:AB_2534069;
1:200).
Microscopy
Indirect flight muscle was dissected and fixed in 4% formaldehyde (Agar scientific; R1926) in PBS for 30 minutes, washed twice with
PBS, and mounted on slides in Prolong Diamond Antifade mounting medium (Thermo Fisher Scientific; RRID:SCR_015961). Larval
epidermal cells were prepared as previously described (Lee et al., 2018). Larvae were dissected in PBS and fixed in 4% formalde-
hyde, for 30min, permeabilized in 0.3%Triton X-100 for 30min, and blockedwith 0.3%Triton X-100 plus 1%bovine serum albumin in
PBS for 1 h at room temperature. Tissues were incubated with anti-ATP5A antibody diluted in 0.3% Triton X-100 plus 1% bovine
serum albumin in PBS overnight at 4C, rinsed three times 10 min with 0.3% Triton X-100 in PBS, and incubated with the appropriate
fluorescent secondary antibodies for 2 h at room temperature. The tissues were washed twice in PBS and mounted on slides using
Prolong Diamond Antifademountingmedium (Thermo Fisher Scientific). Fluorescence imaging was conducted with a Zeiss LSM 880
confocal microscope/Nikon Plan-Apochromat 63x/1.4 NA oil immersion objective. For adult eyes, images were acquired using a
Leica DFC490 camera mounted on a Leica MZ6 stereomicroscope set at maximum zoom.e4 Cell Reports 27, 1541–1550.e1–e5, April 30, 2019
Quantifying Mitochondrial Density
Images of larval epidermal cells we acquired as above and processed in Fiji software (Schindelin et al., 2012). Briefly, images encom-
passing several cells were acquired using a 63x/1.4 NA oil immersion objective. Several 15 mm2 regions, avoiding especially sparse or
dense areas, were selected. Exposure was adjusted using the Threshold function, selecting Otsu type, B&W and Auto. Images were
made binary, and Analyze Particles function was applied (size: 0.1-infinity).
Axonal Transport
Analysis of axonal transport was performed on wandering third instar larvae as previously described (Baldwin et al., 2016). Larvae
were pinned at each end dorsal side up to a Sylgard (Sigma 761028) slide and cut along the dorsal midline using micro-dissection
scissors. Larvae were covered in dissection solution (128 mM NaCl, 1 mM EGTA, 4 mMMgCl2, 2 mM KCl, 5 mM HEPES and 36 mM
sucrose, adjusted to pH 7 using NaOH), the sides were pinned back and the internal organs removed. Movies were taken using a
Nikon E800 microscope with a 60x water immersion lens (NA 1.0 Nikon Fluor WD 2.0) and an LED light source driven by Micro-Man-
ager 1.4.22 Freeware (Edelstein et al., 2014). A CMOS camera (01-OPTIMOS-F-M-16-C) was used to record 100 frames at a rate of 1
frameper 5 s forCCAP-GAL4 samples or 1 frame per 2.5 s forM12-GAL4 samples.Movies were converted into kymographs using Fiji
(Schindelin et al., 2012) and quantified manually.
Respirometry analysis
Respiration was monitored at 30C using an Oxygraph-2k high-resolution respirometer (OROBOROS Instruments) using a chamber
volume set to 2 mL. Calibration with air-saturated medium was performed daily. Data acquisition and analysis were carried out using
Datlab software (OROBOROS Instruments). Five flies per genotype (equal weight) were homogenized in respiration buffer (120 mM
sucrose, 50 mM KCl, 20 mM Tris-HCl, 4 mM KH2PO4, 2 mMMgCl2, and 1 mM EGTA, 1 g/l fatty acid-free BSA, pH 7.2). ForMICU3
27
experiments, 5 heads per genotypewere used. For coupled (state 3) assays, complex I-linked respirationwasmeasured at saturating
concentrations of malate (2 mM), glutamate (10 mM) and adenosine diphosphate (ADP, 2.5 mM). Complex II-linked respiration was
assayed in respiration buffer supplemented with 0.15 mM rotenone, 10 mM succinate and 2.5 mM ADP.
ATP levels
The ATP assaywas performed as described previously (Pogson et al., 2014). Briefly, fivemale flies of the indicated age or 10 larvae for
each genotype were homogenized in 100 mL 6 M guanidine-Tris/EDTA extraction buffer and subjected to rapid freezing in liquid
nitrogen. Homogenates were diluted 1/100 with the extraction buffer and mixed with the luminescent solution (CellTiter-Glo Lumi-
nescent Cell Viability Assay, Promega). Luminescence was measured with a SpectraMax Gemini XPS luminometer (Molecular
Devices). The average luminescent signal from technical triplicates was expressed relative to protein levels, quantified using the
DC Protein Assay kit (Bio-Rad). Data from 2-4 independent experiments were averaged and the luminescence expressed as a per-
centage of the control.
RNA extraction, cDNA synthesis and qRT-PCR
Isolation of total RNA was performed using the RNeasy RNA purification kit (QIAGEN); cDNA was synthesized from total RNA using
ProtoScript II first strand cDNA Synthesis Kit (New England BioLabs, E6560S) according to manufacturer’s instructions. Total RNA
concentration was ascertained spectrophotometrically, and equivalent amounts of total RNA underwent reverse transcription for
each sample. Quantitative real-time PCR (qRT-PCR) was performed on a CFX96 Touch Real-Time PCR Detection System. Gene-
specific primers were designed to have oligos spanning an intron whenever possible. Primer sequences (summarized in Table S1)
were as follows: EMRE forward 50-ACATGTCCAGCGTGTACTTTC-30 and reverse 50-GGTATGACGGCACAGAAGATG-30;MICU1 for-
ward 50-GTGGCCATGGTCAATCTTTC-30 and reverse 50-TTGTTGCTGAGTTGGTTGTCA-30; MICU3 forward 5-GATCCACAAAC
CAAGCGAAT-30 and reverse 50-CCTCTTCCGGCTCTTGCT-30; sulfateless forward 50-AAGCTGTCGATTTGAGTAGCAA-30 and
reverse 50-GACTGTCCACTCGCAATCAG-30; javelin forward 50-GCGGATTTTTCCGTGAATC-30 and reverse 50-TCTGGCTCTGGGT
GTCATC-30; and RpL32 forward 50-GCCGCTTCAAGGGACAGTATCTG-30 and reverse 50-AAACGCGGTTCTGCATGAG-30. Carry-
over DNA was removed with Turbo DNase free (Ambion, Cat. No. AM1907) according to the manufacturer’s protocol. The relative
transcript levels of each target gene were normalized against RpL32mRNA levels; quantification was performed using the compar-
ative CT method (Schmittgen and Livak, 2008).
QUANTIFICATION AND STATISTICAL ANALYSIS
Data are reported as mean ± SD, SEM or 95% confidence interval (CI) as indicated in figure legends. For climbing analysis, Kruskal-
Wallis non-parametric test with Dunn’s post hoc correction for multiple comparisons was used. For lifespan experiments,
significance levels were determined by log-rank tests and reported in the figure legends. Mitochondrial transport was analyzed by
one-way ANOVA, and larval crawling, ATP, and Oroboros measurements analyzed by two-tailed unpaired t test. Unless specifically
indicated, no significant difference was found between a sample and any other sample in the analysis. Where n is indicated in the
figure legends, these refer to biological replicates or number of animals tested. No data points were excluded from the analyses.
Analyses were performed using GraphPad Prism 7 software (RRID:SCR_002798).Cell Reports 27, 1541–1550.e1–e5, April 30, 2019 e5
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Figure S1. Additional characterisation of MCU1 mutants. Related to Figure 1.
A. DNA analysis of MCU1. Primer sequences are detailed in the ‘STAR Methods’ section. The control genotype 
yielded a ~2.5 kb band, compared to ~900 bp for MCU1 homozygotes.
B, C. Relative transcript level of sfl (B) or jv (C) for control and MCU1 flies (mean ±  SD; n = 3).
D. Representative traces of Rhodamine 123 (Rh123) fluorescence (a.u.: arbitrary units) in isolated mitochondria of the 
indicated genotypes used for the Ca2+ uptake assays for MCU (with da-GAL4 expressed UAS-MCU).
E. Relative membrane potential was determined through Rh123 fluorescence change before and after addition of 
FCCP (ΔF-F0) normalized to controls (mean ± SEM; n = 3).
F. The percentage of adult flies eclosing as homozygous MCU1 mutants versus balanced heterozygotes, together with 
the expected Mendelian ratio in the offspring (n > 700). 
The control genotype is w1118. 
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Figure S2. Mitochondrial morphology and dynamics in MCU1 mutants. Related to Figure 1.
A. Mitochondrial morphology of control or MCU1 adult indirect flight muscle at 2, 20, or 40 days post-
eclosion. Scale bar = 10 μm. Genotypes - Control: UAS-mito-HA-GFP/+; da-GAL4/+. MCU1: UAS-mito-HA-
GFP/+; MCU1/MCU1, da-GAL4.
B. Representative kymographs of mitochondrial axonal transport in control and MCU1 larvae. Scale bars: 
horizontal = 20 μm, vertical = 100 s. Genotypes - Control: CCAP-GAL4, UAS-mito.tdTomato/+. MCU1: 
CCAP-GAL4, UAS-mito.tdTomato/+; MCU1/MCU1.
C. Quantification of mitochondrial transport shown in B. Statistical analysis: one-way ANOVA (mean ± 95% 
CI; n = 10; ns, non-significant). 
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Figure S3. Additional characterisation of EMRE1 mutants. Related to Figure 2.
A. RFLP analysis of control and EMRE1 PCR products with BcnI. 
B. Representative traces of Rhodamine 123 (Rh123) fluorescence (a.u.: arbitrary units) in isolated mitochondria of 
the indicated genotypes used for the Ca2+ uptake assays for EMRE mutants.
C. Relative membrane potential was determined through Rh123 fluorescence change before and after addition of 
FCCP (ΔF-F0) normalized to controls (mean ± SEM; n = 3).
D. The percentage of adult flies eclosing as homozygous EMRE1 mutants versus balanced heterozygotes, together 
with the expected Mendelian ratio in the offspring (n > 360).
The control genotype is w1118. 
E. Climbing assay of EMRE1/+ and EMRE1 flies at 2 and 20 days post-eclosion. Statistical analysis: Kruskal-Wallis 
test with Dunn’s post-hoc correction for multiple comparisons (mean ± 95% CI; n > 50; * P < 0.05, ns, non-
significant). 
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Figure S4. Additional characterisation of MICU327 mutants. Related to Figure 4.
A. Representative sequencing chromatograms for wild-type and MICU327 showing the single base deletion 
of MICU327.
B. RFLP analysis of control and MICU327 PCR products with MboII. 
C. The percentage of adult flies eclosing as homozygous MICU327 mutants versus balanced heterozygotes, 
together with the expected Mendelian ratio in the offspring (n > 225). 
The control genotype is w1118. 
D. Climbing assay of MICU327/+ and MICU327 flies at 2 and 20 days post-eclosion. Statistical analysis: 
Kruskal-Wallis test with Dunn’s post-hoc correction for multiple comparisons (mean ± 95% CI; n > 40; * 
P < 0.05, ** P < 0.01). 
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Figure S5. Analysis of transgene expression. Related to Figure 5.
A. Representative images of eye morphology for GMR-GAL4 driven expression of individual uniporter transgenes. 
In all conditions the control genotype was the relevant GAL4-only genetic background control (GAL4/+). 
Scale bar = 100 μm. 
B. Western blot analysis of ubiquitously (da-GAL4) expressed UAS-MCU transgene.
C. Western blot analysis of ubiquitously (da-GAL4) expressed UAS-EMRE-myc transgene.
D. Western blot analysis of transgenic MICU1 expression of UAS-MICU1-A-3xHA and UAS-MICU1-C-HA lines 
using a ubiquitous (arm-GAL4) driver.
E. Western blot analysis of relative MICU3 expression between UAS-MICU3-A-V5 and UAS-MICU3-C-V5 lines 
using a ubiquitous (da-GAL4) driver.
Immunoblots were probed with the indicated antibodies.
Supplementary Table 1 – qPCR Primers (linked to STAR Methods) 
 
REAGENT or RESOURCE SOURCE IDENTIFIER 
EMRE qPCR Forward Primer: 
ACATGTCCAGCGTGTACTTTC 
This paper N/A 
EMRE qPCR Reverse Primer: 
GGTATGACGGCACAGAAGATG 
This paper N/A 
javelin qPCR Forward Primer: 
GCGGATTTTTCCGTGAATC 
This paper N/A 
javelin qPCR Reverse Primer: 
TCTGGCTCTGGGTGTCATC 
This paper N/A 
MICU1 qPCR Forward Primer: 
GTGGCCATGGTCAATCTTTC 
This paper N/A 
MICU1 qPCR Reverse Primer: 
TTGTTGCTGAGTTGGTTGTCA 
This paper N/A 
MICU3 qPCR Forward Primer: 
GATCCACAAACCAAGCGAAT 
This paper N/A 
MICU3 qPCR Reverse Primer: 
CCTCTTCCGGCTCTTGCT 
This paper N/A 
RpL32 qPCR Forward Primer: 
GCCGCTTCAAGGGACAGTATCTG 
This paper N/A 
RpL32 qPCR Reverse Primer:  
AAACGCGGTTCTGCATGAG 
This paper N/A 
sulfateless qPCR Forward Primer: 
AAGCTGTCGATTTGAGTAGCAA 
This paper N/A 
sulfateless qPCR Reverse Primer: 
GACTGTCCACTCGCAATCAG 
This paper N/A 
 
